The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123110372 12311037 2 F 2015 20160808 20160427 20160816 EXP US-BAYER-2015-485630 BAYER 68.00 YR E F Y 0.00000 20160816 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123110372 12311037 1 PS BETASERON INTERFERON BETA-1B 1 Subcutaneous 8 MIU, QOD 44145A 103471 8 MIU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QOD
123110372 12311037 2 SS BETASERON INTERFERON BETA-1B 1 Subcutaneous 6 MIU, QOD 51075A 103471 6 MIU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QOD
123110372 12311037 3 SS BETASERON INTERFERON BETA-1B 1 Subcutaneous 2 MIU, ONCE 51075A 103471 2 MIU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1X
123110372 12311037 4 SS BETASERON INTERFERON BETA-1B 1 Subcutaneous 6 MIU, ONCE 51075A 103471 6 MIU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1X
123110372 12311037 5 SS BETASERON INTERFERON BETA-1B 1 Subcutaneous 6 MIU, QOD 52095A 103471 6 MIU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QOD
123110372 12311037 6 SS BETASERON INTERFERON BETA-1B 1 Subcutaneous 6 MIU, QOD 52198A 103471 6 MIU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QOD
123110372 12311037 7 C TYLENOL ACETAMINOPHEN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123110372 12311037 1 Relapsing-remitting multiple sclerosis
123110372 12311037 2 Relapsing-remitting multiple sclerosis
123110372 12311037 3 Relapsing-remitting multiple sclerosis
123110372 12311037 4 Relapsing-remitting multiple sclerosis
123110372 12311037 5 Relapsing-remitting multiple sclerosis
123110372 12311037 6 Relapsing-remitting multiple sclerosis
123110372 12311037 7 Premedication

Outcome of event

Event ID CASEID OUTC COD
123110372 12311037 HO
123110372 12311037 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123110372 12311037 Activities of daily living impaired
123110372 12311037 Blood sodium decreased
123110372 12311037 Confusional state
123110372 12311037 Cystitis
123110372 12311037 Dizziness
123110372 12311037 Drug dose omission
123110372 12311037 Drug intolerance
123110372 12311037 Ear infection
123110372 12311037 Erythema
123110372 12311037 Fall
123110372 12311037 Fatigue
123110372 12311037 Haematoma
123110372 12311037 Influenza like illness
123110372 12311037 Injury associated with device
123110372 12311037 Malaise
123110372 12311037 Nausea
123110372 12311037 Pain
123110372 12311037 Peripheral swelling
123110372 12311037 Prescribed underdose
123110372 12311037 Product use issue
123110372 12311037 Pyrexia
123110372 12311037 Speech disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123110372 12311037 1 20150825 201512 0
123110372 12311037 2 201512 201602 0
123110372 12311037 3 20160220 20160220 0
123110372 12311037 4 20160221 20160221 0
123110372 12311037 5 201602 0